Chargement en cours...
Safety and effectiveness of Rixubis in patients with hemophilia B: a real-world, prospective, postmarketing surveillance study in South Korea
BACKGROUND: Rixubis (recombinant factor IX, nonacog gamma) is indicated for the control and prevention of bleeding episodes, perioperative management, and routine prophylaxis in hemophilia B patients. This real-world, postmarketing surveillance study aimed to evaluate the safety and effectiveness of...
Enregistré dans:
| Publié dans: | Blood Res |
|---|---|
| Auteurs principaux: | , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7784123/ https://ncbi.nlm.nih.gov/pubmed/33303707 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5045/br.2020.2020225 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|